These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 7006692)
1. Substrate specificity of two chymotrypsin-like proteases from rat mast cells. Studies with peptide 4-nitroanilides and comparison with cathepsin G. Yoshida N; Everitt MT; Neurath H; Woodbury RG; Powers JC Biochemistry; 1980 Dec; 19(25):5799-804. PubMed ID: 7006692 [No Abstract] [Full Text] [Related]
2. Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors. Powers JC; Tanaka T; Harper JW; Minematsu Y; Barker L; Lincoln D; Crumley KV; Fraki JE; Schechter NM; Lazarus GG Biochemistry; 1985 Apr; 24(8):2048-58. PubMed ID: 3893542 [TBL] [Abstract][Full Text] [Related]
3. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates. Harper JW; Cook RR; Roberts CJ; McLaughlin BJ; Powers JC Biochemistry; 1984 Jun; 23(13):2995-3002. PubMed ID: 6380580 [TBL] [Abstract][Full Text] [Related]
4. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. Vartio T; Seppä H; Vaheri A J Biol Chem; 1981 Jan; 256(1):471-7. PubMed ID: 6450204 [No Abstract] [Full Text] [Related]
6. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells. Le Trong H; Neurath H; Woodbury RG Proc Natl Acad Sci U S A; 1987 Jan; 84(2):364-7. PubMed ID: 3540962 [TBL] [Abstract][Full Text] [Related]
7. Human skin chymotryptic proteinase. Isolation and relation to cathepsin g and rat mast cell proteinase I. Schechter NM; Fräki JE; Geesin JC; Lazarus GS J Biol Chem; 1983 Mar; 258(5):2973-8. PubMed ID: 6338010 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin I conversion by human and rat chymotryptic proteinases. Wintroub BU; Schechter NB; Lazarus GS; Kaempfer CE; Schwartz LB J Invest Dermatol; 1984 Nov; 83(5):336-9. PubMed ID: 6092480 [TBL] [Abstract][Full Text] [Related]
9. Importance of secondary enzyme-substrate interactions in human cathepsin G and chymotrypsin II catalysis. Boudier C; Jung ML; Stambolieva N; Bieth JG Arch Biochem Biophys; 1981 Sep; 210(2):790-3. PubMed ID: 6914155 [No Abstract] [Full Text] [Related]
10. Leukoproteinases and pulmonary emphysema: cathepsin G and other chymotrypsin-like proteinases enhance the elastolytic activity of elastase on lung elastin. Boudier C; Laurent P; Bieth JG Adv Exp Med Biol; 1984; 167():313-7. PubMed ID: 6369910 [No Abstract] [Full Text] [Related]
12. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453 [TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Salvesen G; Farley D; Shuman J; Przybyla A; Reilly C; Travis J Biochemistry; 1987 Apr; 26(8):2289-93. PubMed ID: 3304423 [TBL] [Abstract][Full Text] [Related]
14. Human neutrophil and mast cell proteases implicated in inflammation. Rest RF Methods Enzymol; 1988; 163():309-27. PubMed ID: 3070298 [No Abstract] [Full Text] [Related]
15. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions. Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of human chymotrypsin-like proteases by alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin. Hayem A; Marko D; Laine A; Davril M Adv Exp Med Biol; 1988; 240():97-9. PubMed ID: 3266711 [No Abstract] [Full Text] [Related]
18. A comparison of the behavior of chymotrypsin and cathepsin B towards peptidyl diazomethyl ketones. Watanabe H; Green GD; Shaw E Biochem Biophys Res Commun; 1979 Aug; 89(4):1354-60. PubMed ID: 574013 [No Abstract] [Full Text] [Related]
19. Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones. Powers JC; Gupton BF; Harley AD; Nishino N; Whitley RJ Biochim Biophys Acta; 1977 Nov; 485(1):156-66. PubMed ID: 562189 [No Abstract] [Full Text] [Related]
20. [Synthesis of omega-carboxyacyl-L-phenylalanine-aryl esters and their use as substrates for cathepsin G and chymotrypsin]. Schnabel E Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):655-64. PubMed ID: 7275004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]